DANISH BIO COMMODITIES A/S: Financial statements 2020
CVR: 40594264
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
DANISH BIO COMMODITIES A/S (CVR 40594264) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -312,616 and a net result of DKK -1,014,411. Equity in the 2020 report amounted to DKK -141,362. The company had 2 employees in the financial year.
- Gross Profit
- DKK -312,616
- Profit/Loss
- DKK -1,014,411
- Equity
- DKK -141,362
- Total Assets
- DKK 5,365,748
- Employees
- 2
Official annual report
How creditworthy is DANISH BIO COMMODITIES A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
As of November 13, 2020, Lasse Nielsen is registered as director of DANISH BIO COMMODITIES A/S.
DANISH BIO COMMODITIES A/S has published its interim report for the period June 14, 2019 – December 31, 2019.
About DANISH BIO COMMODITIES A/S
DANISH BIO COMMODITIES A/S is a Danish company of the type Aktieselskab based in Kongens Lyngby, founded in 2019. The company is registered under the industry Mægler- og agentaktiviteter i forbindelse med forsyning af elektricitet og naturgas. The management consists of Rune Ledgaard Sørensen. The board consists of Miika Samuel Johansson (chair), Aleksi Juhani Graan and Sakari Olli Iisakki Muroke. The company is owned by DBC Group Holding ApS. According to the 2025 annual report, the company had an average of 17 employees. In 2025, the company reported a gross profit of DKK 27,240,712 and a net result of DKK 4,745,983 compared with DKK -1,059,967 the year before. Equity in the 2025 report amounted to DKK 66,680,402.